Genopole
Genopole is France's leading biocluster, a public-private partnership operating an integrated biotech campus in Évry-Courcouronnes that hosts 78 companies, 16 laboratories, and 23 technology platforms supporting startups, researchers, and academic institutions in genomics and life sciences.
- Company typePrivate
- Founded1998
- HeadquartersÉvry, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Genopole does
Genopole is France's first and leading biocluster, structured as a Groupement d'Intérêt Public (GIP) — a public-private partnership — established in 1998 in Évry-Courcouronnes, 30 km south of Paris. The organization operates an integrated innovation campus spanning 11.5 hectares and 115,000 m² of scientific research infrastructure, hosting 78 biotech companies, 16 academic laboratories, and 23 shared technology platforms that collectively serve approximately 2,400 researchers, entrepreneurs, students, and staff. Genopole structures and animates a genomics and life sciences research hub, supports the growth of innovative biotech enterprises, and reinforces life sciences education via Université d'Évry Paris-Saclay on the campus, with activity organized around three strategic sectors: innovative therapies, industrial biotechnologies, and digital genomics.
Genopole's core technology offering comprises 23 mutualized platforms spanning cellular biology and imaging, molecular biology, structural biology and analytical chemistry, bioproduction, biological resource centers, functional exploration, bioinformatics, and robotics/automation. Specific platforms include GATEX (pilot-scale bioproduction with Techfors-S 10L and 32L bioreactors), Protopia (precision fermentation formulation), MicroScope (microbial genome annotation and comparative phylogenetic analysis), EVRYRNA (non-coding RNA prediction and analysis), OCCIGen (imaging cytometry), and the REVE very high-speed broadband network linking 14 scientific sites across the Évry agglomeration. Genopole runs four main accompaniment programs: Shaker (6-month pre-incubation with shared lab and reagent funding), Gene.iO (1-year early-stage startup acceleration for first funding or commercial agreements), ATIGe (3-year research team creation with €250,000 in funding per team), and Upscale Bio (growth acceleration), complemented by the L'Oréal Green Sciences Incubator @Genopole co-incubation program providing two fully equipped labs.
Genopole's revenue model is anchored in institutional funding from the French State, Île-de-France Region, Essonne Department, Grand Paris Sud agglomeration, City of Évry-Courcouronnes, and AFM-Téléthon, supplemented by service revenues from technology platform access, real estate operations through its wholly-owned subsidiary SEM Genopole, incubation program participation, and co-incubation partnerships. The organization is not venture-backed, has no external equity investors, and operates under shared governance among institutional stakeholders. Its convention was renewed for 9 years in February 2026, with INRAE and CNRS joining as new members, reinforcing its long-term role in French biotech sovereignty and unlocking continued public funding under the France 2030 plan.
Genopole firmographics
Firmographics- Name
- Genopole
- Legal name
- GIP Genopole
- Website
- https://genopole.fr
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Genopole is France's leading biocluster, a public-private partnership operating an integrated biotech campus in Évry-Courcouronnes that hosts 78 companies, 16 laboratories, and 23 technology platforms supporting startups, researchers, and academic institutions in genomics and life sciences.
- Ownership category
- akta.pro rank
Genopole industry classification
Industry- Product category
- Biotechnology Innovation Ecosystem (Biocluster Services)
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)
- akta.pro secondary industries
- Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Biofuel Plant EPC, O&M & Process Technology Providers (EUAAAHAK), Bio-based Solvents & Process Chemicals (e.g., bio-acetone, bio-butanol, bio-IPA, green solvents) (EUAAAIAB)
Keywords
Where Genopole is headquartered
LocationHeadquarters
- HQ city
- Évry
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Genopole business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Public Funding and Subsidies: Genopole is a GIP (Groupement d'Intérêt Public) primarily supported by government funding including the French State, Île-de-France Region, Essonne Department, Grand Paris Sud agglomeration, Evry-Courcouronnes City, and AFM-Téléthon
- Incubation and Support Services: Provides incubation, support programs (Shaker, Gene.iO, ATIGe, Upscale Bio), real estate services, and technology platform access to biotech companies and researchers
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Genopole product offering
Product offeringCore offering
Genopole operates as France's first biocluster, an integrated innovation ecosystem dedicated to biotechnology and life sciences. It delivers four main lines of offerings: (1) structured incubation and acceleration programs (Shaker, Gene.iO, ATIGe, Upscale Bio) that support biotech startups from idea inception through growth; (2) shared access to 23 mutualized technology platforms spanning genomics, bioproduction, imaging, bioinformatics, and structural biology; (3) physical infrastructure including the GATEX bioproduction facility, Protopia precision fermentation laboratory, and real estate/laboratory space on the 11.5-hectare Evry-Courcouronnes campus; and (4) business support services including European funding assistance, international development, training programs, and corporate co-incubation (e.g., L'Oréal Green Sciences Incubator).
Product overview
Genopole is France's leading biocluster - an integrated innovation ecosystem combining incubation/acceleration programs (Shaker, Gene.iO, ATIGe, Upscale Bio), shared technology platforms (GATEX bioproduction, Protopia prototyping, bioinformatics tools, imaging/cytometry, genomics sequencing), and business support services. The ecosystem supports 78 companies, 16 laboratories, and 23 shared platforms across three strategic sectors: innovative therapies, industrial biotechnologies, and digital genomics. Genopole provides physical infrastructure (real estate, laboratories), funding assistance, training programs, and international development support to biotech startups and researchers.
Differentiator
Problem solved
Functional benefit
Brands
- SEM Genopole: Société d'Économie Mixte (SEM) Genopole — the real estate management and property services entity of the Genopole biocluster campus, directed by David Bodet.
- Shaker
- Gene.iO
- ATIGe
- Upscale Bio
- GATEX
- Protopia
- UX CARE
- D4MedTech
- D4Gen Hackathon
- Genopole Partnering Week
- L'Oréal Green Sciences Incubator @Genopole
Products and services
- Shaker Program
- Gene.iO Program
- ATIGe Program
Quantifiable outcome
- Nearly 70% of Shaker program participants have created a startup
- +2 more outcomes
Companies that use Genopole
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Genopole technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature3 records
Genopole partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered regional and core.
- Kawasaki Institute of Industrial Promotion (KIIP)regional3-year partnership to strengthen Franco-Japanese collaborations in biotechnology and advanced therapies. Japanese delegation visited Genopole ecosystem including Abolis, Généthon, and I-STEM institute.
- PUI Innovation Alliance Université Paris-SaclaycoreGenopole joined as founding member of the PUI Innovation Alliance Université Paris-Saclay, a structuring program funded by France 2030 to accelerate technology transfer and deeptech startup emergence.
- ARD (Alliance pour la Recherche et le Développement)corePartnership to accelerate industrialization of biotechnologies in France. Aims to create a continuum between research, biofoundry and biomanufacturing, strengthening the French bioeconomy sector.
- Université Paris-SaclaycoreStrategic partnership to strengthen collaboration in biotechnology innovation. Genopole is the biotechnology actor of the scientific and technological pole of Paris-Saclay.
- GenoThercoreBiocluster project labeled under France 2030 including Généthon, Genopole, AP-HP, Inserm, Université d'Evry Paris-Saclay, Spark Therapeutics, Yposkesi. Focus on gene therapy industrialization.
- L'Oréal Green Sciences Incubator @GenopolecoreCo-incubation program where startups receive scientific support (two fully equipped labs with L'Oréal experts) and business acceleration (fundraising, market access, partnerships, communication). First incubated: Algentech and Novobiom.
Scale indicators8 records
Recent moves15 records
Expansion highlights6 records
Genopole competitors and assessment
Company assessmentDirect peers
- BioGenerator: St. Louis-based nonprofit startup creator and investor specialized in bioscience company formation. Comparable to Genopole's ATIGe and Shaker programs in early-stage biotech venture creation.
- BioEnterprise (Cleveland): US Midwest life sciences accelerator supporting biotech and medical device startups through infrastructure and partnerships. Comparable to Genopole in the regional biotech cluster model.
- MaRS Discovery District: Toronto-based innovation hub combining startup incubation, lab infrastructure, and corporate partnerships across health, biotech, and clean tech. Directly comparable to Genopole as a public-purpose biocluster anchoring university research and biotech scale-up.
- JLABS (Johnson & Johnson Innovation): Johnson & Johnson's global network of life-science incubators providing lab facilities, mentorship, and corporate partnership access to biotech startups. Comparable in providing shared infrastructure and corporate-anchored incubation.
- One Nucleus (UK): Life sciences and healthcare membership organization in the UK operating in the Cambridge/London cluster, providing networking, training, and infrastructure support. Comparable in serving as a regional biotech ecosystem anchor.
- BioM (Munich Biotech Cluster): Germany's leading biotech cluster management organization, supporting startups, infrastructure, and academic-industrial collaboration in Bavaria. Direct European peer in the biocluster operating model.
- Medicen Paris Region: French competitiveness cluster focused on health, biotech, and medtech innovation in Île-de-France. Directly competes with Genopole for French biotech startups, public funding, and corporate partnerships.
- Karolinska Innovations: Innovation hub commercializing research from Karolinska Institutet in Sweden's biotech cluster. Comparable in the university-anchored biotech incubation model.
Regional players
- Station F: Paris-based mega-incubator with a biotech program track. Same geography as Genopole, partially overlapping in startup support, but broader (tech-focused) and lacking Genopole's dedicated bioproduction platforms.
Broad incumbents
- CIC (Cambridge Innovation Center): Large US operator of shared innovation campuses including wet-lab and biotech space. Broader in scope (multi-sector) but directly comparable in delivering shared lab infrastructure and incubation services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Genopole social profiles
Digital presenceGenopole compliance and trust
Trust signalCompliance2 records
Genopole financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genopole leadership team
Management profileNumber of profiles
Profiles6 records
Genopole subsidiaries and ownership
Company hierarchySubsidiaries1 record
Genopole funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genopole M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genopole
What does Genopole do?
Genopole operates as France's first biocluster, an integrated innovation ecosystem dedicated to biotechnology and life sciences. It delivers four main lines of offerings: (1) structured incubation and acceleration programs (Shaker, Gene.iO, ATIGe, Upscale Bio) that support biotech startups from idea inception through growth; (2) shared access to 23 mutualized technology platforms spanning genomics, bioproduction, imaging, bioinformatics, and structural biology; (3) physical infrastructure including the GATEX bioproduction facility, Protopia precision fermentation laboratory, and real estate/laboratory space on the 11.5-hectare Evry-Courcouronnes campus; and (4) business support services including European funding assistance, international development, training programs, and corporate co-incubation (e.g., L'Oréal Green Sciences Incubator).
Is Genopole a public or private company?
Genopole is a private company. It is classified as state government owned and is currently operating.
When was Genopole founded?
Genopole was founded in 1998. It employs 11 to 50 people.
Where is Genopole based?
Genopole is headquartered in Évry, France, in the Europe region.
How does Genopole make money?
Two revenue lines are on record. Public Funding and Subsidies are the primary driver. The others are incubation and Support Services.
Who are Genopole's main competitors?
Direct peers on record are BioGenerator, BioEnterprise (Cleveland), MaRS Discovery District, JLABS (Johnson & Johnson Innovation), One Nucleus (UK), BioM (Munich Biotech Cluster), Medicen Paris Region and Karolinska Innovations. Station F is listed as a regional player. CIC (Cambridge Innovation Center) is listed as a broad incumbent.
Does Genopole have an API?
No public API is recorded for Genopole.
What industry is Genopole in?
Genopole's product category is Biotechnology Innovation Ecosystem (Biocluster Services). Its primary akta.pro industry code is HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling), with a secondary code of HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream). Its NAICS code is 541714 and its SIC code is 8731.